Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.C.J., K.S., R.A.M., W.L.D., H.I.A.); and School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom (G.H.)
Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia (J.C.J., K.S., R.A.M., W.L.D., H.I.A.); and School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom (G.H.).
Mol Pharmacol. 2018 May;93(5):417-426. doi: 10.1124/mol.117.110775. Epub 2018 Feb 21.
Oxycodone is a semisynthetic opioid compound that is widely prescribed, used, and abused today, and has a well-established role in shaping the current opioid epidemic. Previously, we have shown that tolerance develops to the antinociceptive and respiratory depressive effects of oxycodone in mice, and that a moderate dose of acute ethanol or a protein kinase C (PKC) inhibitor reversed that tolerance. To investigate further if tolerance was occurring through neuronal mechanisms, our aims for this study were to assess the effects of acute and prolonged oxycodone in isolated dorsal root ganglia (DRG) neurons and to determine if this tolerance was reversed by either ethanol or a PKC inhibitor. We found that an acute exposure to 3 M oxycodone reduced neuronal excitability, as measured by increased threshold potentials and reduced action potential amplitude, without eliciting measurable changes in resting membrane potential. Exposure to 10 M oxycodone for 18-24 hours prevented oxycodone's effect on neuronal excitability, indicative of tolerance development. The development of opioid tolerance was mitigated in DRG neurons from -arrestin 2 knockout mice. Oxycodone tolerance was reversed in isolated DRG neurons by the acute application of either ethanol (20 mM) or the PKC inhibitor, bisindolylmaleimide XI hydrochloride (Bis XI), when a challenge of 3 M oxycodone significantly reduced neuronal excitability following prolonged exposure. Through these studies, we concluded that oxycodone acutely reduced neuronal excitability, tolerance developed to this effect, and reversal of that tolerance occurred at the level of a single neuron, suggesting that reversal of oxycodone tolerance by either ethanol or Bis XI involves cellular mechanisms.
羟考酮是一种半合成阿片类化合物,目前被广泛应用于医疗,并被滥用,在当前的阿片类药物流行中发挥了重要作用。此前,我们已经证明,在小鼠中,羟考酮的镇痛和呼吸抑制作用会产生耐受,而中等剂量的急性乙醇或蛋白激酶 C(PKC)抑制剂可以逆转这种耐受。为了进一步研究这种耐受是否是通过神经元机制产生的,我们的研究目的是评估急性和长期羟考酮对分离的背根神经节(DRG)神经元的影响,并确定乙醇或 PKC 抑制剂是否可以逆转这种耐受。我们发现,急性暴露于 3 M 羟考酮会降低神经元兴奋性,表现为阈电位增加和动作电位幅度降低,而静息膜电位没有发生可测量的变化。暴露于 10 M 羟考酮 18-24 小时会阻止羟考酮对神经元兴奋性的作用,表明耐受的发展。-arrestin 2 敲除小鼠的 DRG 神经元中,阿片类药物耐受的发展得到缓解。在分离的 DRG 神经元中,急性应用乙醇(20 mM)或 PKC 抑制剂双吲哚马来酰亚胺 XI 盐酸盐(Bis XI)可以逆转羟考酮的耐受,当长时间暴露后,3 M 羟考酮的挑战会显著降低神经元兴奋性。通过这些研究,我们得出结论,羟考酮会急性降低神经元兴奋性,对这种作用会产生耐受,而这种耐受可以在单个神经元水平上逆转,这表明乙醇或 Bis XI 逆转羟考酮耐受涉及细胞机制。